Energast now available to support management of GI disorders

A new food supplement is now available to support the dietary management of gastrointestinal disorders, including diarrhoea and constipation.1

Energast may assist in the management of Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD) diverticulitis and diarrhoea of different causes.

The supplement, distributed by SciGen (Australia) Pty Ltd, contains sodium butyrate – the predominant short chain fatty acid (SCFA) beneficial for colonic health.2

Manufactured with sustained release technology, Energast can uniquely deliver sodium butyrate along the entire small and large intestine, where it’s needed.

Dosage

Adults: 1 capsule, twice-a-day with food, for at least 3 months, or as recommended by a healthcare professional.

Children aged 7 years and above: 1 capsule, once-a-day with food, for at least 6 weeks, or as recommended by a healthcare professional.

As a dietary food for special medical purpose, Energast can be added to existing therapies under medical supervision in combination with a balanced diet.

RRP: $30.00 (box of 60 capsules)
Stockists inquiries: Available from API, product code 36940. SciGen (Australia) Pty Ltd 1800 676 833. Visit: energast.com.au

Energast Pharmacy Training Presentation

References

1. Tarnowski, W., et. al. Outcome of treatment with butyric acid in irritable bowel syndrome – preliminary report. Gastroenterologia Praktyczna, 2011:1(8),43-48.

2. Canani RB., et al. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol, 2011: 17(12), 1519-1528.